{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:35:07Z","timestamp":1787834107164,"version":"build-2784847793"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2403,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1111\/j.1365-2133.2008.08853.x","type":"journal-article","created":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T23:53:40Z","timestamp":1221868420000},"page":"403-408","source":"Crossref","is-referenced-by-count":22,"title":["Topical treatment for human papillomavirus-associated genital warts in humans with the novel tellurium immunomodulator AS101: assessment of its safety and efficacy"],"prefix":"10.1093","volume":"160","author":[{"given":"M.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Letko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Duvdevani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Zavaro-Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Albeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sredni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0738-081X(97)00008-4","article-title":"Human papilomaviruses: general features","volume":"15","author":"Favre","year":"1997","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1396-0296.2004.04047.x","article-title":"Therapy of cutaneous human papillomavirus infections","volume":"17","author":"Rivera","year":"2004","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/sti.2003.008300","article-title":"Sexual behaviour: related adverse health burden in the United States","volume":"81","author":"Ebrahim","year":"2005","journal-title":"Sex Transm Infect"},{"issue":"Suppl.","key":"10.1111\/j.1365-2133.2008.08853.x-BIB4","first-page":"52","article-title":"American Social Health Association Panel. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States","volume":"26","author":"Cates","year":"1999","journal-title":"Sex Transm Dis"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1365-4362.2002.01597.x","article-title":"Imiquimod; an international update on therapeutic uses in dermatology","volume":"41","author":"Tyring","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479","article-title":"Chapter 1: Human papillomavirus and cervical cancer - burden and assessment of causality","volume":"31","author":"Bosch","year":"2003","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.7326\/0003-4819-123-5-199509010-00008","article-title":"Antiviral therapy for human papillomaviruses: rationale and prospects","volume":"123","author":"Phelps","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.0366-077X.2003.05623.x","article-title":"Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum","volume":"149","author":"Hengge","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB9","first-page":"2335","article-title":"Management of genital warts","volume":"70","author":"Kodner","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/cimm.1997.1087","article-title":"The immunomodulator AS-101 inhibits IL-10 release and augments TNF alpha and IL-1 alpha release by mouse and human mononuclear phagocytes","volume":"176","author":"Strassmann","year":"1997","journal-title":"Cell Immunol"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB11","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1158\/0008-5472.CAN-03-3179","article-title":"Ammonium trichloro (dioxoethylene-O,O\u2019) tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop","volume":"64","author":"Sredni","year":"2004","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/330173a0","article-title":"A new immunomodulating compound (AS-101) with potential therapeutic application","volume":"330","author":"Sredni","year":"1987","journal-title":"Nature"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB13","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/jnci\/88.18.1276","article-title":"Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101","volume":"88","author":"Sredni","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/cimm.1998.1251","article-title":"The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB\/c mice","volume":"184","author":"Rosenblatt-Bin","year":"1998","journal-title":"Cell Immunol"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB15","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.4049\/jimmunol.159.6.2658","article-title":"Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels","volume":"159","author":"Kalechman","year":"1997","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4049\/jimmunol.169.1.384","article-title":"Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention","volume":"169","author":"Kalechman","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/aid.1992.8.613","article-title":"Inhibition of the reverse transcriptase activity and replication of human immunodeficiency virus type 1 by AS 101 in vitro","volume":"8","author":"Vonsover","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB18","first-page":"251","article-title":"Human papillomavirus and lower genital neoplasia in renal transplant patients","volume":"68","author":"Halpert","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0002-9378(91)90620-7","article-title":"Human immunodeficiency virus-induced immunosuppression: a risk factor for human papillomavirus infection","volume":"164","author":"Matorras","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3121\/cmr.4.4.273","article-title":"An armamentarium of wart treatments","volume":"4","author":"Lipke","year":"2006","journal-title":"Clin Med Res"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB21","first-page":"163","article-title":"The biological activity and immunotherapeutic properties of AS-101, a synthetic organotellurium compound","volume":"7","author":"Sredni","year":"1988","journal-title":"Nat Immun Cell Growth Regul"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB22","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1200\/JCO.1995.13.9.2342","article-title":"Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide","volume":"13","author":"Sredni","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB23","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.4049\/jimmunol.161.7.3536","article-title":"Up-regulation by ammonium trichloro (dioxoethylene-O,O\u2019) tellurate (AS101) of Fas\/Apo-1 expression on B16 melanoma cells: implications for the antitumor effects of AS101","volume":"161","author":"Kalechman","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB24","first-page":"182","article-title":"Immunologic effects of AS101 in the treatment of cancer patients","volume":"9","author":"Shani","year":"1990","journal-title":"Nat Immun Cell Growth Regul"},{"key":"10.1111\/j.1365-2133.2008.08853.x-BIB25","first-page":"473","article-title":"Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatin","volume":"70","author":"Sredni","year":"1990","journal-title":"Immunology"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2008.08853.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2008.08853.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T01:00:43Z","timestamp":1684544443000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/160\/2\/403\/6641967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08853.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}